Breaking News
Sort by:
Top Post
NHS Trials Smart Goggles to Give Nurses More Time With Patients
High tech goggles will be worn by community nurses on home visits to free up […]
Abbott Announces Future of Biowearables at Consumer Electronics Show
Making CES history, Abbott (NYSE: ABT) presented a keynote at the most influential tech event in the world, […]
BICO and Nanochon Announce Commercial Agreement to Develop 3D Printed Joint Restoration Implant
Today BICO, the world’s leading bio convergence company, announced partnership with Nanochon, a startup developing regenerative joint replacements. Under […]
HypnoVR Raises €4.5 Million to Accelerate the Roll Out of its Digital Therapy Treating Pain and Anxiety
HypnoVR, a market leader in the field of digital therapies to manage pain and stress, […]
Abbott's New Leadless Pacemaker System Meets Primary Endpoints in Pivotal Trial
Abbott (NYSE: ABT) today announced new, late-breaking data from the global Leadless II IDE study evaluating […]
Top Pharmaceutical Companies and CROs Rely on Vivalink for Real-World Patient Data in Decentralized Clinical Trials
Due to limitations necessitated by COVID-19, clinical trials have undergone a transformation. In tandem with […]
XRHealth and Reducept Offer Patients Virtual Reality Therapy for Pain Management
XRHealth, the leader in extended reality and therapeutic applications, announced today that they are working with Reducept […]
Zimmer Biomet and Canary Medical Announce FDA De Novo Classification Grant and Authorization to Market the World's First and Only Smart Knee Implant
Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology leader, and Canary […]
Lifesum Helps Users Improve Daily Health with Samsung Galaxy Watch4 Series
Lifesum, the leading global nutrition app that helps users improve baseline health through better eating, […]
ZOLL Announces Approval of Next-Generation Remedē System for the Treatment of Central Sleep Apnea
ZOLL ® Medical Corporation, an Asahi Kasei company that manufactures medical devices and related software solutions, […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more